Literature DB >> 21270336

Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.

Ali H Ellebedy1, Christopher Lupfer, Hazem E Ghoneim, Jennifer DeBeauchamp, Thirumala-Devi Kanneganti, Richard J Webby.   

Abstract

Clinical studies have indicated that subvirion inactivated vaccines against avian influenza viruses, particularly H5N1, are poorly immunogenic in humans. As a consequence, the use of adjuvants has been championed for the efficient vaccination of a naïve population against avian influenza. Aluminum salts (alum) and the oil-in-water emulsion MF59 are safe and effective adjuvants that are being used with influenza vaccines, but the mechanism underlying their stimulation of the immune system remains poorly understood. It was shown recently that activation of a cytosolic innate immune-sensing complex known as "NLR-Pyrin domain containing 3" (NLRP3) inflammasome, also known as "cryopyrin," "cold-induced autoinflammatory syndrome 1" (CIAS1), or nacht domain-, leucine-rich repeat-, and PYD-containing protein 3 (Nalp3), is essential for the adjuvant effect of alum. Here we show that the inflammasome component apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), an adapter protein within the NLRP3 inflammasome, is a crucial element in the adjuvant effect of MF59 when combined with H5N1 subunit vaccines. In the absence of ASC, H5-specific IgG antibody responses are significantly reduced, whereas the responses are intact in NLRP3(-/-) and caspase-1(-/-) mice. This defect is caused mainly by the failure of antigen-specific B cells to switch from IgM to IgG production. We conclude that ASC plays an inflammasome-independent role in the induction of antigen-specific humoral immunity after vaccination with MF59-adjuvanted influenza vaccines. These findings have important implications for the rational design of next-generation adjuvants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270336      PMCID: PMC3041074          DOI: 10.1073/pnas.1012455108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Authors:  John J Treanor; James D Campbell; Kenneth M Zangwill; Thomas Rowe; Mark Wolff
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

2.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

3.  Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

Authors:  Robert L Atmar; Wendy A Keitel; Shital M Patel; Jacqueline M Katz; Dewei She; Hana El Sahly; Justine Pompey; Thomas R Cate; Robert B Couch
Journal:  Clin Infect Dis       Date:  2006-09-25       Impact factor: 9.079

Review 4.  Intracellular NOD-like receptors in host defense and disease.

Authors:  Thirumala-Devi Kanneganti; Mohamed Lamkanfi; Gabriel Núñez
Journal:  Immunity       Date:  2007-10       Impact factor: 31.745

5.  Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis.

Authors:  Patrick J Shaw; John R Lukens; Samir Burns; Hongbo Chi; Maureen A McGargill; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

6.  Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

Authors:  Iain Stephenson; Roberto Bugarini; Karl G Nicholson; Audino Podda; John M Wood; Maria C Zambon; Jacqueline M Katz
Journal:  J Infect Dis       Date:  2005-03-14       Impact factor: 5.226

7.  NALP3: a key player in caspase-1 activation.

Authors:  Fayyaz S Sutterwala; Yasunori Ogura; Dario S Zamboni; Craig R Roy; Richard A Flavell
Journal:  J Endotoxin Res       Date:  2006

8.  Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

Authors:  Jean-Louis Bresson; Christian Perronne; Odile Launay; Catherine Gerdil; Melanie Saville; John Wood; Katja Höschler; Maria C Zambon
Journal:  Lancet       Date:  2006-05-20       Impact factor: 79.321

9.  Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

Authors:  Andreas Wack; Barbara C Baudner; Anne K Hilbert; Ilaria Manini; Sandra Nuti; Simona Tavarini; Hanno Scheffczik; Mildred Ugozzoli; Manmohan Singh; Jina Kazzaz; Emanuele Montomoli; Giuseppe Del Giudice; Rino Rappuoli; Derek T O'Hagan
Journal:  Vaccine       Date:  2007-12-07       Impact factor: 3.641

10.  Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine.

Authors:  I Stephenson; J M Wood; K G Nicholson; A Charlett; M C Zambon
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

View more
  53 in total

Review 1.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 2.  Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines.

Authors:  Brianne R Barker; Debra J Taxman; Jenny P-Y Ting
Journal:  Curr Opin Immunol       Date:  2011-08-10       Impact factor: 7.486

Review 3.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

4.  How squalene GLAdly helps generate antigen-specific T cells via antigen-carrying neutrophils and IL-18.

Authors:  Justin D Kedl; Ross M Kedl
Journal:  Eur J Immunol       Date:  2015-02       Impact factor: 5.532

Review 5.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

6.  AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality.

Authors:  Hongbo Zhang; Jiadi Luo; John F Alcorn; Kong Chen; Songqing Fan; Joseph Pilewski; Aizhong Liu; Wei Chen; Jay K Kolls; Jieru Wang
Journal:  J Immunol       Date:  2017-04-19       Impact factor: 5.422

7.  Antigen depots: T cell traps?

Authors:  Sacha Gnjatic; Nina Bhardwaj
Journal:  Nat Med       Date:  2013-04       Impact factor: 53.440

Review 8.  Influenza immunization during pregnancy: Benefits for mother and infant.

Authors:  Isaac G Sakala; Yoshikazu Honda-Okubo; Johnson Fung; Nikolai Petrovsky
Journal:  Hum Vaccin Immunother       Date:  2016-08-05       Impact factor: 3.452

Review 9.  Immunobiology of influenza vaccines.

Authors:  Margarita M Gomez Lorenzo; Matthew J Fenton
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

10.  Genetic relationships of antibody response, viremia level, and weight gain in pigs experimentally infected with porcine reproductive and respiratory syndrome virus1.

Authors:  Andrew S Hess; Ben R Trible; Melanie K Hess; Raymond R Rowland; Joan K Lunney; Graham S Plastow; Jack C M Dekkers
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.